Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.2M Sell
277,686
-35,159
-11% -$4.61M 0.08% 209
2025
Q4
$42.6M Buy
312,845
+79,959
+34% +$11.5M 0.1% 172
2025
Q3
$34.4M Buy
232,886
+37,300
+19% +$5.17M 0.09% 199
2025
Q2
$25.3M Sell
195,586
-2,081
-1% -$252K 0.06% 247
2025
Q1
$23.6M Sell
197,667
-279,539
-59% -$34.6M 0.07% 221
2024
Q4
$55.4M Buy
477,206
+35,949
+8% +$4.54M 0.17% 101
2024
Q3
$59.6M Buy
441,257
+9,566
+2% +$1.28M 0.2% 88
2024
Q2
$58.6M Sell
431,691
-596,349
-58% -$81.1M 0.22% 81
2024
Q1
$133M Buy
+1,028,040
New +$124M 0.42% 43

Other funds holding XYL

Danske Bank's XYL Position: Q1 2026 in Review

Danske Bank reduced its Xylem (XYL) stake by 11% in Q1 2026, selling an estimated $4.61M and leaving 277,686 shares worth $33.2M. The position accounts for 0.08% of the portfolio, ranked #209.

Danske Bank first reported a position in XYL in Q1 2024 and has held it in 9 quarters since. The position peaked at $133M in Q1 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Danske Bank held 277,686 shares of Xylem worth $33.2M as of Q1 2026.
  • Danske Bank sold 35,159 Xylem shares in Q1 2026, an estimated $4.61M.
  • Xylem made up 0.08% of Danske Bank's portfolio in Q1 2026, its #209 holding.
  • Danske Bank first reported a position in Xylem in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's Xylem position peaked at $133M in Q1 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.